Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS)

作者：Maurizio De Luca, Scott A. Shikora, Dan Eisenberg, Luigi Angrisani, Chetan Parmar, Aayed Alqahtani, Ali Aminian, Edo O. Aarts, Wendy Brown, Ricardo V. Cohen, Nicola Di Lorenzo, Sílvia Leite Faria, Kasey Goodpaster, Ashraf Haddad, Miguel F. Herrera, Raul J. Rosenthal, Jacqués Himpens, Angelo Iossa, Mohammad Kermansaravi, Lilian Kow, Marina Kurian, Sonja Chiappetta, Teresa LaMasters, Kamal Mahawar, Giovanni Merola, Abdelrahman Nimeri, Mary O’Kane, Pavlos Papasavas, Giacomo Piatto, Jaime Ponce, Gerhard Prager, Janey S.A. Pratt, Ann M. Rogers, Paulina Salminen, Kimberley E. Steele, Michel Suter, Salvatore Tolone, Antonio Vitiello, Marco Antonio Zappa, Shanu N. Kothari · 发表于：Obesity Surgery · 年份：2024 · 被引用次数：68 · 研究领域：Bariatric Surgery and Outcomes、Diet and metabolism studies、Obesity and Health Practices

The 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) updated the indications for Metabolic and Bariatric Surgery (MBS), replacing the previous guidelines established by the NIH over 30 years ago. The evidence supporting these updated guidelines has been strengthened to assist metabolic and bariatric surgeons, nutritionists, and other members of multidisciplinary teams, as well as patients. This study aims to assess the level of evidence and the strength of recommendations compared to the previously published criteria.